SUWANEE, Ga., July 20, 2017 -- Digirad Corporation (NASDAQ:DRAD) will release financial results for its second quarter ended June 30, 2017, before the market opens on Friday, August 4, 2017.
A conference call is scheduled for 11:00 a.m. EDT (8:00 a.m. PDT) on August 4, 2017 to discuss the results and management's outlook. The call may be accessed by dialing 1-877-407-9039 (international callers +1-201-689-8470). A simultaneous webcast of the call may be accessed online from the Events & Presentations link on the Investor Relations page of the Digirad website at http://drad.client.shareholder.com; an archived replay of the webcast will be available within 15 minutes of the end of the conference call.
About Digirad
Digirad delivers convenient, effective, and efficient healthcare solutions on an as needed, when needed, and where needed basis. Digirad's diverse portfolio of mobile healthcare solutions and medical equipment and services, including diagnostic imaging and patient monitoring, provides hospitals, physician practices, and imaging centers throughout the United States access to technology and services necessary to provide exceptional patient care in the rapidly changing healthcare environment. For more information, please visit www.digirad.com.
For more information contact: Jeffry Keyes Chief Financial Officer 858-726-1600 [email protected]


Microsoft's $10 Billion Japan Investment: AI Infrastructure and Data Sovereignty Push
TSMC Japan's Second Fab to Produce 3nm Chips by 2028
Paramount Skydance Secures $24B from Gulf Sovereign Wealth Funds for Warner Bros. Discovery Takeover
UPS and Teamsters Reach Agreement to Limit Driver Severance Program
Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers
Apple Turns 50: From Garage Startup to AI Crossroads
Luxury Car Sales in the Middle East Take a Hit Amid Iran War
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
First Western Ship Transits Strait of Hormuz Since Iran War Began
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
UAE's Largest Natural Gas Facility Suspended After Attack-Triggered Fire
Ukrainian Drones and the #MadeByHousewives Movement: Kyiv Fires Back at Rheinmetall CEO
Britain Courts Anthropic Amid US Defense Department Dispute
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit
SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition
MATCH Act Targets ASML and Chinese Chipmakers in New U.S. Export Crackdown
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports 



